Physician
University Physician Group
University Physician Group was paid $87.27M by Medicaid between Jan 2018 and Dec 2024, across 378 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 13% of everything it billed.
33Billing provider infoUNIVERSITY PHYSICIAN GROUP
DETROIT, MI 48201
DETROIT, MI 48201
33aNPI1447299797assigned 06/05/2006
33bProvider typeTransplant Surgery Physician
28Total paid$87.27M
24GClaims1,695,287
24DCodes billed378
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 270,914 | $14.03M | |
| 2019 | 251,832 | $12.55M | |
| 2020 | 231,855 | $10.91M | |
| 2021 | 249,776 | $12.85M | |
| 2022 | 247,985 | $12.51M | |
| 2023 | 239,159 | $13.14M | |
| 2024incomplete | 203,766 | $11.28M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 182,816 | 167,471 | $11.27M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 7.6% | 162,793 | 35,631 | $6.65M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.2% | 129,723 | 122,474 | $5.45M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 5.0% | 73,109 | 17,115 | $4.32M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.0% | 39,486 | 39,057 | $3.46M |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 3.8% | 4,382 | 4,315 | $3.29M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.8% | 29,547 | 28,195 | $2.48M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.7% | 62,287 | 56,160 | $2.37M |
| J0178 | Injection, aflibercept, 1 mg | 2.3% | 1,938 | 1,752 | $2.01M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2.3% | 16,547 | 3,903 | $2.00M |
| 99222 | Initial hospital care, per day, moderate complexity | 2.3% | 26,357 | 21,588 | $1.97M |
| 59514 | 2.0% | 2,067 | 2,041 | $1.75M |
366 more codes
| 99223 | Prolong inpt eval add15 m | 2.0% | 16,080 | $1.71M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.9% | 26,226 | $1.68M |
| 99203 | Doctor's office visit, new patient (routine) | 1.9% | 30,275 | $1.68M |
| 88307 | 1.9% | 30,811 | $1.67M | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1.6% | 13,838 | $1.38M |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.5% | 16,352 | $1.33M |
| 59426 | 1.5% | 1,935 | $1.30M | |
| 99205 | Prolong outpt/office vis | 1.3% | 10,296 | $1.12M |
| 99254 | 1.2% | 11,459 | $1.02M | |
| 99284 | Emergency room visit (serious) | <1% | 12,871 | $853K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 20,169 | $827K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 29,527 | $680K |
| 77427 | <1% | 6,325 | $666K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 12,384 | $652K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 13,416 | $625K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 289 | $593K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 22,231 | $586K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 9,777 | $545K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 1,902 | $537K |
| 67228 | <1% | 2,851 | $524K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 5,652 | $513K |
| 59425 | <1% | 1,443 | $502K | |
| 99283 | Emergency room visit (moderate) | <1% | 9,349 | $487K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 3,438 | $483K |
| 99221 | <1% | 9,044 | $478K | |
| 92083 | <1% | 14,646 | $470K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 20,336 | $464K |
| 99253 | <1% | 7,534 | $464K | |
| 77014 | <1% | 18,697 | $452K | |
| 99245 | <1% | 3,628 | $414K | |
| 99243 | <1% | 6,784 | $374K | |
| 95720 | <1% | 3,127 | $359K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 9,509 | $359K |
| 88341 | <1% | 6,449 | $328K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 4,507 | $327K |
| 99255 | <1% | 2,932 | $324K | |
| 92134 | <1% | 16,094 | $321K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 985 | $320K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 3,260 | $315K |
| 17110 | <1% | 5,137 | $314K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 3,446 | $289K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 4,457 | $285K |
| 31575 | <1% | 4,946 | $269K | |
| 92015 | Determination of refractive state | <1% | 26,405 | $269K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 5,325 | $267K |
| 95951 | <1% | 1,685 | $251K | |
| 92133 | <1% | 13,629 | $248K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 5,053 | $247K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 5,456 | $240K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 3,739 | $240K |
| 59430 | <1% | 1,578 | $231K | |
| 96910 | <1% | 3,650 | $226K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 6,915 | $221K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 1,378 | $210K |
| 95886 | <1% | 4,715 | $203K | |
| 88141 | <1% | 13,509 | $201K | |
| 88342 | <1% | 8,835 | $191K | |
| 99385 | <1% | 2,094 | $187K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 8,264 | $185K |
| 90837 | Psychotherapy session, about an hour | <1% | 2,345 | $176K |
| 36512 | <1% | 2,956 | $175K | |
| 77263 | <1% | 1,774 | $163K | |
| 77334 | <1% | 3,058 | $160K | |
| 11900 | <1% | 5,961 | $159K | |
| 54150 | <1% | 2,794 | $155K | |
| 99386 | <1% | 1,371 | $146K | |
| 92235 | <1% | 2,379 | $145K | |
| 88312 | <1% | 8,003 | $142K | |
| 92250 | <1% | 6,198 | $138K | |
| 95910 | <1% | 2,293 | $137K | |
| 59025 | Fetal non-stress test | <1% | 7,698 | $137K |
| 99285 | Emergency room visit (most serious) | <1% | 1,406 | $132K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 1,434 | $123K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 5,156 | $122K |
| 77300 | <1% | 2,149 | $115K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 1,764 | $114K |
| 31231 | <1% | 1,122 | $108K | |
| 43235 | <1% | 1,905 | $105K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 5,265 | $103K |
| 59510 | <1% | 43 | $100K | |
| 99219 | <1% | 1,393 | $97K | |
| 90756 | <1% | 3,953 | $96K | |
| 77295 | <1% | 782 | $96K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 9,836 | $94K |
| 76801 | <1% | 2,870 | $94K | |
| 76519 | <1% | 3,054 | $91K | |
| 88331 | <1% | 1,507 | $90K | |
| 76820 | <1% | 5,988 | $89K | |
| 77338 | <1% | 724 | $87K | |
| 88304 | <1% | 11,383 | $85K | |
| 77301 | <1% | 355 | $80K | |
| 76821 | <1% | 3,426 | $78K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 11,400 | $76K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,137 | $76K |
| 99252 | <1% | 1,934 | $75K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 8,634 | $74K |
| 95811 | <1% | 1,070 | $73K | |
| 88321 | <1% | 1,433 | $71K | |
| 88112 | <1% | 4,332 | $68K | |
| 99217 | <1% | 1,816 | $66K | |
| 88173 | <1% | 1,554 | $63K | |
| 93308 | <1% | 3,414 | $63K | |
| 95911 | <1% | 858 | $62K | |
| 99442 | <1% | 2,108 | $61K | |
| 99218 | <1% | 1,089 | $57K | |
| 76813 | <1% | 1,617 | $57K | |
| 90732 | <1% | 527 | $55K | |
| 88309 | <1% | 625 | $54K | |
| 84165 | <1% | 5,384 | $53K | |
| 93356 | <1% | 3,898 | $51K | |
| 93298 | <1% | 2,190 | $51K | |
| 77290 | <1% | 1,144 | $51K | |
| 11102 | <1% | 947 | $49K | |
| 95819 | <1% | 1,537 | $48K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,654 | $48K |
| 90670 | <1% | 401 | $47K | |
| 95718 | <1% | 637 | $47K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 532 | $47K |
| 93351 | <1% | 746 | $46K | |
| 95816 | <1% | 1,433 | $46K | |
| 92201 | <1% | 3,450 | $44K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,169 | $43K |
| 99242 | <1% | 1,116 | $43K | |
| 58300 | <1% | 1,165 | $43K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 585 | $42K |
| 52000 | <1% | 459 | $42K | |
| 92020 | <1% | 2,918 | $41K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,584 | $40K |
| 47562 | <1% | 113 | $39K | |
| 86334 | <1% | 3,827 | $38K | |
| 11104 | <1% | 528 | $36K | |
| 92002 | <1% | 798 | $35K | |
| 92557 | <1% | 1,694 | $35K | |
| 92341 | <1% | 1,881 | $35K | |
| 82962 | <1% | 13,426 | $33K | |
| 20610 | <1% | 1,198 | $33K | |
| 90715 | <1% | 1,089 | $32K | |
| 76830 | Ultrasound, transvaginal | <1% | 505 | $32K |
| 76512 | <1% | 959 | $30K | |
| 90746 | <1% | 502 | $29K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 409 | $29K |
| 99443 | <1% | 1,043 | $28K | |
| 88311 | <1% | 3,365 | $27K | |
| 92060 | <1% | 757 | $26K | |
| 99235 | <1% | 286 | $26K | |
| 90677 | <1% | 108 | $26K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,168 | $26K |
| 58558 | <1% | 191 | $25K | |
| 88313 | <1% | 2,135 | $25K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 409 | $25K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 436 | $24K |
| 11100 | <1% | 445 | $24K | |
| V2020 | Frames, purchases | <1% | 1,670 | $23K |
| 81025 | <1% | 3,467 | $23K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 301 | $22K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 620 | $22K |
| 76514 | <1% | 3,568 | $22K | |
| 93299 | <1% | 319 | $21K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,119 | $20K |
| 94726 | <1% | 2,888 | $20K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 1,381 | $20K |
| 99441 | <1% | 1,077 | $19K | |
| 57454 | <1% | 240 | $19K | |
| 85060 | <1% | 1,840 | $18K | |
| 88302 | <1% | 3,475 | $18K | |
| 90674 | <1% | 629 | $18K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 7,038 | $18K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 341 | $18K |
| 36556 | <1% | 364 | $17K | |
| 68761 | <1% | 179 | $16K | |
| 11901 | <1% | 500 | $16K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 390 | $16K |
| 77280 | <1% | 749 | $15K | |
| 69210 | <1% | 545 | $15K | |
| 94729 | <1% | 2,906 | $15K | |
| 92567 | <1% | 1,680 | $15K | |
| 88300 | <1% | 5,733 | $15K | |
| 93000 | <1% | 1,715 | $15K | |
| 96900 | <1% | 1,117 | $15K | |
| 93321 | <1% | 2,747 | $14K | |
| 77307 | <1% | 176 | $14K | |
| 93297 | <1% | 441 | $14K | |
| 95908 | <1% | 360 | $14K | |
| 99201 | <1% | 721 | $14K | |
| 93295 | <1% | 565 | $14K | |
| 88361 | <1% | 189 | $14K | |
| 76825 | <1% | 254 | $13K | |
| 99220 | <1% | 134 | $13K | |
| 88360 | <1% | 426 | $13K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,694 | $12K |
| 93296 | <1% | 909 | $12K | |
| 73564 | <1% | 466 | $12K | |
| 93325 | <1% | 3,698 | $12K | |
| 94375 | <1% | 1,400 | $12K | |
| 76376 | <1% | 1,207 | $12K | |
| 65855 | <1% | 81 | $11K | |
| 90651 | <1% | 115 | $11K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 1,126 | $11K |
| 93312 | <1% | 180 | $11K | |
| 86580 | <1% | 2,045 | $11K | |
| 58301 | <1% | 234 | $11K | |
| 88177 | <1% | 398 | $10K | |
| 94060 | <1% | 1,501 | $10K | |
| 90661 | <1% | 326 | $10K | |
| 88172 | <1% | 477 | $10K | |
| 92025 | <1% | 507 | $10K | |
| 43246 | <1% | 112 | $9K | |
| 84166 | <1% | 917 | $9K | |
| 88189 | <1% | 210 | $9K | |
| 86335 | <1% | 865 | $9K | |
| 66982 | <1% | 31 | $8K | |
| 67113 | <1% | 21 | $8K | |
| 66821 | <1% | 52 | $8K | |
| 31622 | <1% | 147 | $8K | |
| 35701 | <1% | 45 | $7K | |
| 99234 | <1% | 98 | $7K | |
| 87210 | <1% | 1,611 | $6K | |
| 90961 | <1% | 55 | $6K | |
| 92225 | <1% | 414 | $6K | |
| 93320 | <1% | 493 | $6K | |
| 94618 | <1% | 481 | $6K | |
| 15100 | <1% | 17 | $6K | |
| 36620 | <1% | 226 | $5K | |
| 95250 | <1% | 61 | $5K | |
| 96127 | <1% | 1,767 | $5K | |
| 88332 | <1% | 80 | $4K | |
| 76827 | <1% | 253 | $4K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 93 | $4K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 102 | $4K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 38 | $4K |
| 17000 | <1% | 138 | $4K | |
| 88142 | <1% | 1,197 | $4K | |
| 31624 | <1% | 69 | $4K | |
| 15002 | <1% | 34 | $4K | |
| 81002 | <1% | 1,911 | $4K | |
| 90750 | <1% | 28 | $4K | |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 520 | $4K |
| 31615 | <1% | 62 | $3K | |
| 90632 | <1% | 68 | $3K | |
| 15004 | <1% | 25 | $3K | |
| 83986 | <1% | 1,373 | $3K | |
| 93285 | <1% | 87 | $3K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 3,166 | $3K |
| 93352 | <1% | 359 | $3K | |
| 99451 | <1% | 141 | $3K | |
| 92226 | <1% | 235 | $3K | |
| 99490 | Ccm add 20min | <1% | 79 | $3K |
| 77470 | <1% | 49 | $3K | |
| J3590 | Unclassified biologics | <1% | 120 | $3K |
| 92285 | <1% | 221 | $3K | |
| 90966 | <1% | 23 | $3K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 558 | $3K |
| 88108 | <1% | 190 | $3K | |
| 99241 | <1% | 124 | $3K | |
| 88365 | <1% | 93 | $2K | |
| 99000 | <1% | 629 | $2K | |
| 90688 | <1% | 193 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 63 | $2K |
| 87101 | <1% | 496 | $2K | |
| 91322 | <1% | 14 | $2K | |
| G0452 | Molecular pathology procedure; physician interpretation and report | <1% | 3,274 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 878 | $2K |
| 99251 | <1% | 72 | $2K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 44 | $2K |
| 99381 | <1% | 25 | $2K | |
| 80504 | <1% | 53 | $2K | |
| 95721 | <1% | 14 | $2K | |
| 99349 | <1% | 26 | $2K | |
| 85097 | <1% | 50 | $2K | |
| 73560 | <1% | 76 | $1K | |
| 95909 | <1% | 27 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 90 | $1K |
| 12032 | <1% | 12 | $1K | |
| 93018 | <1% | 152 | $1K | |
| 95808 | <1% | 25 | $1K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 38 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,280 | $1K |
| 11981 | <1% | 27 | $1K | |
| 10022 | <1% | 12 | $1K | |
| 10061 | <1% | 12 | $1K | |
| 54056 | <1% | 14 | $1K | |
| 99406 | <1% | 167 | $1K | |
| 95912 | <1% | 12 | $1K | |
| 80502 | <1% | 27 | $1K | |
| 11101 | <1% | 49 | $1K | |
| G0008 | Administration of influenza virus vaccine | <1% | 228 | $1K |
| 92275 | <1% | 12 | $1K | |
| 51798 | <1% | 122 | $1K | |
| 76942 | <1% | 37 | $1K | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 12 | $971.53 |
| 91200 | <1% | 124 | $942.79 | |
| 99383 | <1% | 13 | $934.54 | |
| 88104 | <1% | 60 | $902.10 | |
| 57456 | <1% | 14 | $855.07 | |
| 94010 | <1% | 156 | $777.04 | |
| 92082 | <1% | 30 | $774.97 | |
| 88187 | <1% | 39 | $756.25 | |
| 0064A | <1% | 29 | $751.88 | |
| 76812 | <1% | 14 | $741.68 | |
| 76857 | <1% | 30 | $737.38 | |
| 99459 | <1% | 53 | $724.00 | |
| 10060 | <1% | 15 | $715.39 | |
| 51701 | <1% | 30 | $672.25 | |
| 73522 | <1% | 26 | $621.53 | |
| 87590 | <1% | 37 | $600.75 | |
| 93016 | <1% | 51 | $600.29 | |
| 90480 | <1% | 14 | $563.72 | |
| 11200 | <1% | 12 | $541.98 | |
| 95251 | <1% | 27 | $524.86 | |
| 87490 | <1% | 37 | $508.68 | |
| 95822 | <1% | 15 | $496.20 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 48 | $495.19 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 64 | $483.76 |
| 93350 | <1% | 12 | $480.24 | |
| 0124A | <1% | 86 | $463.99 | |
| 96415 | <1% | 29 | $449.05 | |
| 77261 | <1% | 12 | $402.10 | |
| 90734 | <1% | 13 | $379.75 | |
| 0094A | <1% | 12 | $375.30 | |
| 90694 | <1% | 51 | $373.03 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 17 | $339.36 |
| 80305 | <1% | 61 | $327.64 | |
| 73562 | <1% | 15 | $316.19 | |
| 99417 | Prolong home eval add 15m | <1% | 13 | $303.36 |
| 88329 | <1% | 12 | $301.92 | |
| 76377 | <1% | 14 | $292.95 | |
| 51741 | <1% | 64 | $289.22 | |
| 93294 | <1% | 13 | $226.99 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 20 | $215.43 |
| 85610 | <1% | 66 | $195.86 | |
| Q2039 | Influenza virus vaccine, not otherwise specified | <1% | 16 | $163.70 |
| J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | <1% | 29 | $152.76 |
| 92551 | <1% | 23 | $142.04 | |
| 80500 | <1% | 12 | $141.35 | |
| 95885 | <1% | 12 | $117.70 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 175 | $113.29 |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 12 | $105.60 |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | <1% | 14 | $88.03 |
| 90653 | <1% | 13 | $87.66 | |
| 0134A | <1% | 132 | $79.96 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 13 | $59.20 |
| 87220 | <1% | 12 | $34.97 | |
| 85018 | <1% | 24 | $34.72 | |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | <1% | 266 | $30.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12 | $5.96 |
| 90611 | <1% | 372 | $0.04 | |
| 99024 | <1% | 33,998 | $0.01 | |
| 3044F | 0% | 851 | $0.00 | |
| 0501F | 0% | 14,078 | $0.00 | |
| 0503F | 0% | 4,600 | $0.00 | |
| 0500F | 0% | 5,106 | $0.00 | |
| 91305 | 0% | 29 | $0.00 | |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 0% | 102 | $0.00 |
| 3052F | 0% | 50 | $0.00 | |
| 3046F | 0% | 598 | $0.00 | |
| 3051F | 0% | 158 | $0.00 | |
| 0502F | 0% | 8,825 | $0.00 | |
| 91313 | 0% | 106 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 542 | $0.00 |
| 3045F | 0% | 90 | $0.00 | |
| 92504 | 0% | 54 | $0.00 | |
| 90461 | 0% | 15 | $0.00 | |
| 91312 | 0% | 77 | $0.00 | |
| G2089 | Most recent hemoglobin a1c (hba1c) level 7.0 to 9.0% | 0% | 14 | $0.00 |
| 99173 | 0% | 37 | $0.00 | |
| 90633 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJUZYCH, MARK (PRESIDENT & CEO, WAYNE HEALTH)